Speaker(s): 
Kirsten Mascaritola, PharmD; Taylor Warner, PharmD; and Chidubem Ifeji, PharmD, Geisinger Pharmacy Residents, have nothing to disclose.

Moderator(s): 
Adriene Zook, PharmD, RPH, Geisinger Pharmacy, has nothing to disclose.

Learning Objectives: 
At the conclusion of this session, the participant should be able to: 

1. Evaluate pertinent updates to the ADA guidelines published for 2024
2. Identify treatment goals for patient with diabetes based on age, comorbidities, and compelling indications
3. Apply guideline directed pharmacological recommendations to special populations

Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Stacy Coolbaugh, MBA, RDN, LDN; Angela Esherick, RDN, LDN, CDCES; Adriene Zook, PharmD, RPH, Dan Huston, DNP, RN, BC-ADM, and Angela Zammit have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 
This presentation/content is HIPPA compliant.